What GLP-1 Drugs Are Doing to the Brain
Post • June 12, 2026
If it feels like everyone is talking about Ozempic, Wegovy, Zepbound, or Mounjaro these days, you're not imagining things. What began as a treatment for type 2 diabetes has become a cultural phenomenon. Mill...
How to Reduce Microplastics at Home (and What Experts Say Actually Helps)
Media Appearances • 2026-06-10
Brain Defenders: Harness the Power of Your Immune Cells to Protect Your Brain for Life
Media Appearances • 2026-06-11
The #1 Food Habit Associated With Dementia Risk
Post • June 11, 2026
For decades, the search for the cause of Alzheimer's disease has focused on genes, amyloid plaques, and the promise of new medications. But a growing body of research is revealing something far more immediat...
The Brain Defenders Assessment: Thank You
Page • June 11, 2026
You're in! Your Brain Defenders Assessment is on its way. Check your inbox — we just sent your personalized assessment to the email address you provided. (If you don't see it in the next few minutes, be s...
Your Anxiety Is a Metabolic Problem, Not a Mental One | Dr. Robin Berzin
Video • June 10, 2026
Why Metabolic Flexibility Is Central to Longevity In a world overwhelmed with conflicting health advice, it can be hard to know what truly moves the needle on longevity, resilience, and sustained vitali...
What Night Shift Work May Be Doing to Your Brain
Post • June 8, 2026
Whenever I give talks about brain health, someone almost always asks a version of the same question: "How can I get the benefits of good sleep if I have to work at night?" It's a great question because mil...
Shift work is associated with selective brain volume loss: a longitudinal study
Study • September 9, 2025
GLP-1 drugs like Ozempic may be rewiring the brain, and a neurologist explains what that really means
Media Appearances • 2026-06-07